logo
  • 首页
  • 学术期刊
  • 论文检测
  • AIGC检测
  • 热点
  • 更多
    • 数据

AntifungalsMulti-drug resistance, and transient rash following off-label use: case report

被引:0
|
作者:
机构:
来源:
Reactions Weekly | 2023年 / 1945卷 / 1期
关键词:
D O I:
10.1007/s40278-023-34147-8
中图分类号:
学科分类号:
摘要:
引用
收藏
页码:66 / 66
相关论文
共 50 条
  • [21] NivolumabFever following off-label use: case report
    Reactions Weekly, 2016, 1601 (1) : 186 - 186
  • [22] FavipiravirNephrotoxicity following off-label use: case report
    Reactions Weekly, 2022, 1929 (1) : 283 - 283
  • [23] DexamfetamineHypertension following off-label use: case report
    Reactions Weekly, 2021, 1883 (1) : 150 - 150
  • [24] DexamethasoneHyperglycaemia following off-label use: case report
    Reactions Weekly, 2022, 1896 (1) : 173 - 173
  • [25] TocilizumabAnaphylaxis following off-label use: case report
    Reactions Weekly, 2021, 1865 (1) : 397 - 397
  • [26] MirtazapineTachyphylaxis following off-label use: case report
    Reactions Weekly, 2018, 1703 (1) : 182 - 182
  • [27] RituximabPancytopenia following off-label use: case report
    Reactions Weekly, 2020, 1807 (1) : 176 - 176
  • [28] Multiple drugsLack of drug effect following off-label use: case report
    Reactions Weekly, 2021, 1856 (1) : 289 - 289
  • [29] FavipiravirDisseminated erythematous drug eruption following an off-label use: case report
    Reactions Weekly, 2023, 1982 (1) : 188 - 188
  • [30] DexamethasoneMucormycosis following off-label use: case report
    Reactions Weekly, 2023, 1956 (1) : 181 - 181
← 12345 →